TEVA Forecast



Bearish<—>Bullish



80% Confidence




Bullish Case: TEVA's strategic focus on biosimilars, coupled with ongoing debt reduction efforts, positions it as a resilient player in the volatile pharmaceutical market, potentially driving price recovery.




Bearish Case: Persistent legal challenges, competitive pressures, and tariff threats overshadow growth initiatives, maintaining downside risks. Elevated implied volatility indicates ongoing market caution.




Potential Outcomes:
  • 35% Chance: Responsive growth through effective litigation management and strategic shifts, moving price to $18.
  • 40% Chance: Continued pressure from legal matters and market dynamics, keeping price around $15.
  • 25% Chance: Rapid innovation push boosts market sentiment, lifting price to $20.



April 24, 2025


Teva- Pharmaceutical Industries Forecast

TEVA        Teva- Pharmaceutical Industries
















Become a more profitable trader with AI optimized trading strategies






×

Chat with TEVA


 Ask any question about TEVA!